Liu Weipeng, Li Zongrui, Li Xiaopeng, Cao Haiyang, Jiang He, Niu Qingbin, Hu Baoguang
Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong 256603, P.R. China.
Breast Treatment Center, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong 271000, P.R. China.
Oncol Lett. 2023 Nov 2;26(6):541. doi: 10.3892/ol.2023.14128. eCollection 2023 Dec.
Cancer tissues harbor a large microbiome. There is growing evidence that the tumor microbiome is significantly correlated with the prognosis of cancer patients, but the exact underlying mechanisms have remained elusive. Although the tumor mycobiome is less abundant than the biome of bacteria, it is prevalent in most cancers in humans. The present review describes in detail the impact of the tumor mycobiome on cancer pathogenesis. The tumor mycobiome promotes tumor progression and metastasis by affecting the human immune system, maintaining a pro-inflammatory environment, producing aflatoxins, attenuating cell adhesion mechanisms and fungal-bacterial interactions. Furthermore, the tumor mycobiome likewise has great potential for cancer prevention, diagnosis and treatment.
癌组织中存在大量微生物群落。越来越多的证据表明,肿瘤微生物群落与癌症患者的预后显著相关,但其确切的潜在机制仍不清楚。尽管肿瘤真菌微生物群落的数量比细菌群落少,但在大多数人类癌症中都普遍存在。本综述详细描述了肿瘤真菌微生物群落对癌症发病机制的影响。肿瘤真菌微生物群落通过影响人体免疫系统、维持促炎环境、产生黄曲霉毒素、减弱细胞黏附机制以及真菌与细菌的相互作用来促进肿瘤进展和转移。此外,肿瘤真菌微生物群落在癌症预防、诊断和治疗方面同样具有巨大潜力。